Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials

Remdesivir was among the first antiviral therapies to be tested in RCTs for COVID-19. At a follow-up of 28-29 days, the use of remdesivir was not asso...

Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study

The study involved 18 patients with COVID-19 infection (laboratory-confirmed) severe pneumonia. Each treatment involved the administration of whole bl...

Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomized clinical trial (COVID HELMET)

Oxygen delivery by helmet continuous positive airway pressure (CPAP) is a feasible option. It enables a higher positive positive end-expiratory press...

Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies

Age and sex are associated with the risk of COVID-19 in different severity stages ranging from infection to death. Patients aged 70 years and above ha...

Systematic review on current antiviral therapy in COVID-19 pandemic

There are several attempts to find an effective antiviral drug against the COVID-19. Up to 5-10% of patients may have severe, life-threatening events...

Acute kidney injury and renal replacement therapy in COVID-19 patients: A systematic review and meta-analysis

A meta-analysis conducted to gain clarity regarding AKI incidence and renal replacement therapy (RRT) use in COVID-19 patients. We searched for COVID...